US stocks retreat after big Monday rally

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 44 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 21%
  • Publisher: 66%

Malaysia News News

Malaysia Malaysia Latest News,Malaysia Malaysia Headlines

NEW YORK: Wall Street stocks ended lower on Tuesday (May 19) as top US economic officials warned the US economy faces continued risks, causing the ...

NEW YORK: Wall Street stocks ended lower on Tuesday as top US economic officials warned the US economy faces continued risks, causing the market to give back some of the gains from the prior session.

It is not unusual to see a pullback in stocks after a big rally, but a high-profile Capitol Hill hearing highlighted lingering concerns on how to safely revive the economy, analysts said. The White House has urged states to reopen their economies as quickly as is safely possible and has not embraced the need to approve additional fiscal support right now - a stance taken by congressional Democrats.Federal Reserve Chair Jerome Powell has in recent days suggested that more will be needed to ease the unprecedented economic pain, but was careful during the hearing not to stray into recommending more spending - the purview of Congress.

In Tuesday's session, Southwest Airlines rose 2.2 per cent as it reported a"modest improvement" in demand in May after bookings more than offset cancellations for the first time since the COVID-19 crisis.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Ya don't say🤔

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in MY

Malaysia Malaysia Latest News, Malaysia Malaysia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Trump to tap new company to make Covid-19 drugs in the USWASHINGTON (NYTIMES) - The Trump administration will announce Tuesday (May 19) that it has signed a US$354 million (S$502 million) four-year contract with a new company in Richmond, Virginia, to manufacture generic medicines and pharmaceutical ingredients that are needed to treat Covid-19 but are now made overseas, mostly in India and China.. Read more at straitstimes.com.
Source: The Straits Times - 🏆 8. / 63 Read more »